首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: An update
【24h】

PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: An update

机译:PI3K-Akt-mTOR和MAPK信号通路在多囊卵巢综合征,子宫平滑肌瘤和子宫内膜异位症中的最新进展

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PI3K-Akt-mTOR and MAP kinase are two important cell signaling pathways that are activated by steroid hormones and growth factors leading to cellular events including gene expression, cell proliferation and survival. These pathways are considered as an attractive target for the development of novel anticancer molecules, and selective inhibitors specifically targeting different components of these cascades have been developed. This review summarizes the current available knowledge on the PI3K-Akt-mTOR and MAPK pathways and their targeting in estrogen-dependent benign gynecological disorders viz. polycystic ovarian syndrome, uterine leiomyomas and endometriosis, which are a significant cause of high morbidity in women of reproductive age group. Increasing knowledge about the role of the two growth regulatory pathways in the pathogenesis of these disorders may give the opportunity to use specific signal transduction inhibitors for management of these patients in future.
机译:PI3K-Akt-mTOR和MAP激酶是两个重要的细胞信号通路,被类固醇激素和生长因子激活,导致细胞事件,包括基因表达,细胞增殖和存活。这些途径被认为是开发新型抗癌分子的有吸引力的靶标,并且已经开发了特异性靶向这些级联反应的不同组分的选择性抑制剂。这篇综述总结了关于PI3K-Akt-mTOR和MAPK途径及其在雌激素依赖性良性妇科疾病中的靶向作用的现有知识。多囊卵巢综合征,子宫平滑肌瘤和子宫内膜异位症是育龄妇女高发病率的重要原因。对这两种疾病的发病机理中两种生长调节途径的作用的认识的增加可能为将来使用特异性信号转导抑制剂治疗这些患者提供机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号